Sponsored by Johnson & Johnson.
Understanding bipolar depression & its family ties
Vickie, a mom of two adult sons, was diagnosed with bipolar I depression in her early twenties. Bipolar depression is part of a larger mental health condition called bipolar disorder, which causes extreme changes in mood and behavior. These changes in mood, known as mood episodes, can cause people to experience lows (bipolar depression) and highs (mania).

“I’ve learned that bipolar disorder can be a hereditary disease. My husband and I have adult twin sons, and one of them has been diagnosed with bipolar I depression, just like me.”
-Vickie, living with bipolar I depression

Vickie was diagnosed in her early 20s
At first, Vickie had a hard time adjusting to her diagnosis of bipolar I depression. It took her some time to understand and identify with it because she felt there was a stigma around the word “bipolar”. Since then, she has come to accept it and learn as much about it as she can.

The search begins for the right treatment plan
Vickie, like many others with bipolar I depression, devoted considerable time and effort to finding the right treatment plan. She's had a lot of counseling and tried many different prescription medications, facing challenges along the way, including side effects such as weight gain.
Discussing her options with Dr. Roma
Vickie talked with her psychiatrist about her goals and her options, which was how she learned about CAPLYTA® (lumateperone).
CAPLYTA is a prescription medication used in adults for the treatment of depressive episodes associated with bipolar I or bipolar II disorder (bipolar depression). CAPLYTA can be taken alone or with the medicines lithium or valproate for bipolar depression. It is not known if CAPLYTA is safe and effective in children.
CAPLYTA has Boxed WARNINGS for increased risk of death in elderly people with dementia-related psychosis and increased risk of suicidal thoughts and behaviors in children and young adults. CAPLYTA is not approved for people under 18. See additional Important Safety Information below.
“CAPLYTA not only has proven efficacy in reducing depressive symptoms from bipolar I and II, but it has a well-established safety profile and it’s generally well tolerated for most patients.”
-Dr. Roma, Vickie's psychiatrist
Patient experiences may vary.
Dr. Roma appreciates the dosing schedule of CAPLYTA—just one pill, once a day, taken with or without food, and patients start on the effective dose. While every patient’s experience with CAPLYTA will be different, Dr. Roma thought Vickie would find success with CAPLYTA.

Finding symptom relief for her bipolar I depression with CAPLYTA
Vickie was excited about the idea of trying CAPLYTA, especially after learning that in clinical trials, weight gain and movement disorders were not common, which was important to her.
CAPLYTA may cause weight gain. You and your healthcare provider should monitor your weight.
CAPLYTA may cause serious side effects, including uncontrolled body movements (tardive dyskinesia, TD) in your face, tongue, or other body parts. TD may not go away, even if you stop taking CAPLYTA. It may also occur after you stop taking CAPLYTA.
Please see additional Important Safety Information below.

“I tell my patients that CAPLYTA is proven to deliver meaningful symptom relief from both bipolar I and II depression. They may see some improvement in the first week with additional relief over the course of six weeks.”
-Dr. Roma, Vickie's psychiatrist
Patient experiences may vary.
Vickie and her doctor went over the most common side effects for CAPLYTA, her other existing medical conditions, and any additional medications she was taking before deciding to move forward with treatment. Said Vickie, "I took one pill, once a day, right before bedtime. About two to three weeks after starting treatment with CAPLYTA, I felt some improvement in my bipolar depression symptoms. And I was so encouraged by that."
The most common side effects of CAPLYTA include sleepiness, dizziness, nausea, dry mouth, feeling tired, and diarrhea. CAPLYTA can cause sleepiness and trouble concentrating. Until you know how CAPLYTA affects you, do not drive, operate heavy machinery, or do other dangerous activities. These are not all the possible side effects. Please see additional Important Safety Information below.

“I’m becoming more of an advocate not only for myself but also for our adult son...I want him to see that bipolar I depression is a condition that he can live with and manage and still thrive.”
-Vickie, living with bipolar I depression
Patient experiences may vary.
Today, Vickie feels that since taking CAPLYTA along with regular counseling, her symptoms seem less overwhelming.
Being open-minded and proactive about managing her bipolar depression with her doctor helped Vickie find a treatment plan that works for her.
If you’re interested in learning more about CAPLYTA from your healthcare provider, download our Doctor Discussion Guide at CAPLYTA.com to help start the conversation.
Watch Vickie's story about living with bipolar I depression.
The patient and healthcare provider in this promotional article are sharing their individual experiences and have been compensated for their time. This promotional resource is brought to you by Johnson & Johnson.
IMPORTANT SAFETY INFORMATION
What is the most important information I should know about CAPLYTA®?
- Medicines like CAPLYTA® can raise the risk of death in elderly people who have lost touch with reality (psychosis) due to confusion and memory loss (dementia). CAPLYTA® is not approved for treating people with dementia-related psychosis.
- CAPLYTA® and antidepressant medicines increase the risk of suicidal thoughts and actions in people 24 years of age and younger, especially within the first few months of treatment or when the dose is changed. Depression and other serious mental illnesses are the most important causes of suicidal thoughts and actions.
- Patients and their families or caregivers should watch for new or worsening depression symptoms, especially sudden changes in mood, behaviors, thoughts, or feelings. This is very important when CAPLYTA® or an antidepressant medicine is started or when the dose is changed.
- Report any changes in these symptoms to your healthcare provider immediately.
- thoughts about suicide or dying
- new or worse depression
- feeling very agitated or restless
- trouble sleeping
- acting aggressive, being angry or violent
- new or worse anxiety
- suicide attempts
- an extreme increase in activity and talking (mania)
- panic attacks
- new or worse irritability
- acting on dangerous impulses
- other unusual changes in behavior or mood
- Do not take CAPLYTA® if you are allergic to any of its ingredients. Get emergency medical help if you are having an allergic reaction (e.g., rash, itching, hives, swelling of the tongue, lip, face, or throat).
What are the possible side effects of CAPLYTA®?
CAPLYTA® may cause serious side effects, including:
- Stroke (cerebrovascular problems) in elderly people with dementia-related psychosis that can lead to death.
- Neuroleptic malignant syndrome (NMS): high fever, confusion, changes in your breathing, heart rate, and blood pressure, stiff muscles, and increased sweating; these may be symptoms of a rare but potentially fatal condition. Contact your healthcare provider or go to the emergency room if you experience signs and symptoms of NMS.
- Uncontrolled body movements (tardive dyskinesia, TD) in your face, tongue, or other body parts. TD may not go away, even if you stop taking CAPLYTA®. It may also occur after you stop taking CAPLYTA®.
- Problems with your metabolism including high blood sugar, diabetes, increased fat (cholesterol and triglyceride) levels in your blood and weight gain. Your healthcare provider should check your blood sugar, fat levels, and weight before you start and during your treatment with CAPLYTA®.
- Extremely high blood sugar levels can lead to coma or death. Call your healthcare provider if you have any of the following symptoms of high blood sugar: feeling very thirsty, hungry, sick to your stomach, needing to urinate more than usual, weak/tired, or confused, or your breath smells fruity.
- Low white blood cell count. Your healthcare provider may do blood tests during the first few months of treatment with CAPLYTA®.
- Decreased blood pressure (orthostatic hypotension). You may feel lightheaded, dizzy, or faint when you rise too quickly from a sitting or lying position.
- Falls. CAPLYTA® may make you sleepy or dizzy, may cause a decrease in your blood pressure when changing position (orthostatic hypotension), and can slow your thinking and motor skills which may lead to falls that can cause broken bones or other injuries.
- Seizures (convulsions).
- Sleepiness, drowsiness, feeling tired, difficulty thinking and doing normal activities. Until you know how CAPLYTA® affects you, do not drive, operate heavy machinery, or do other dangerous activities.
- Problems controlling your body temperature so that you feel too warm. Avoid getting overheated or dehydrated while taking CAPLYTA®.
- Difficulty swallowing that can cause food or liquid to get into the lungs.
- The most common side effects of CAPLYTA® include sleepiness, dizziness, nausea, dry mouth, feeling tired, and diarrhea.
These are not all the possible side effects of CAPLYTA®.
Before taking CAPLYTA®, tell your healthcare provider about all of your medical conditions, including if you: have or have had heart problems or a stroke, high or low blood pressure, diabetes, or high blood sugar, problems with cholesterol, have or have had a low white blood cell count, seizures (convulsions), or kidney or liver problems.
CAPLYTA® may cause fertility problems in females and males. You should notify your healthcare provider if you become pregnant or intend to become pregnant while taking CAPLYTA®. There is a pregnancy registry for females who are exposed to CAPLYTA® during pregnancy. CAPLYTA® may cause abnormal involuntary movements and/or withdrawal symptoms in newborn babies exposed to CAPLYTA® during the third trimester. Talk to your healthcare provider if you breastfeed or are planning to breastfeed as CAPLYTA® passes into breast milk.
Tell your healthcare provider about all the medicines you’re taking. CAPLYTA® may affect the way other medicines work, and other medicines may affect how CAPLYTA® works, causing possible serious side effects. Do not start or stop any medicines while taking CAPLYTA® without talking to your healthcare provider. You are encouraged to report negative side effects of prescription drugs. Contact Intra-Cellular Therapies, Inc. at 1-888-611-4824 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
CAPLYTA® is available in 42 mg, 21 mg, and 10.5 mg capsules.
What is CAPLYTA® (lumateperone)?
CAPLYTA® (lumateperone) is a prescription medicine used in adults to treat depressive episodes associated with bipolar I or bipolar II disorder (bipolar depression) alone or with lithium or valproate. It is not known if CAPLYTA® is safe and effective in children.
US-CAP-2500883
Please see full Prescribing Information, including Boxed WARNINGS, and Medication Guide for CAPLYTA®.
© Johnson & Johnson and its affiliates 2026
CAPLYTA is a trademark of Johnson & Johnson and its affiliates.
Third party trademarks listed are the property of their respective owners.
02/26 US-CAP-2600073


